Oncodesign Precision Medicine S.A. (ALOPM) Price & Analysis

2 Followers

ALOPM Stock Chart & Stats

€0.46

-€0.01(-1.43%)

At close: Jan 08 4:00 PM EST

€0.46

-€0.01(-1.43%)

Day’s Range― - ―

52-Week Range€0.31 - €0.92

Previous CloseN/A

Volume28.87K

Average Volume (3M)14.94K

Market Cap

€6.15M

Enterprise Value€9.54M

Total Cash (Recent Filing)N/A

Total Debt (Recent Filing)N/A

Price to Earnings (P/E)1.1

Beta0.12

Next Earnings

Sep 22, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.24

Shares Outstanding19,136,126

10 Day Avg. Volume12,734

30 Day Avg. Volume14,935

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)0.00

Price to Sales (P/S)0.00

P/FCF Ratio0.00

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)4.03

Revenue Forecast (FY)€101.80M

Oncodesign Precision Medicine S.A. News

Oncodesign Precision Medicine’s REVERT Study: A New Hope for Resistant Melanoma

Oncodesign Precision Medicine S.A. (($FR:ALOPM)) announced an update on their ongoing clinical study. Oncodesign Precision Medicine S.A. has...

9M ago

ALOPM

ALOPM FAQ

What was Oncodesign Precision Medicine S.A.’s price range in the past 12 months?

Oncodesign Precision Medicine S.A. lowest stock price was €0.31 and its highest was €0.92 in the past 12 months.

What is Oncodesign Precision Medicine S.A.’s market cap?

Oncodesign Precision Medicine S.A.’s market cap is €6.15M.

When is Oncodesign Precision Medicine S.A.’s upcoming earnings report date?

Oncodesign Precision Medicine S.A.’s upcoming earnings report date is Sep 22, 2026 which is in 46 days.

How were Oncodesign Precision Medicine S.A.’s earnings last quarter?

Oncodesign Precision Medicine S.A. released its earnings results on Apr 30, 2026. The company reported -€0.237 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.237.

Is Oncodesign Precision Medicine S.A. overvalued?

According to Wall Street analysts Oncodesign Precision Medicine S.A.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Oncodesign Precision Medicine S.A. pay dividends?

Oncodesign Precision Medicine S.A. does not currently pay dividends.

What is Oncodesign Precision Medicine S.A.’s EPS estimate?

Oncodesign Precision Medicine S.A.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Oncodesign Precision Medicine S.A. have?

Oncodesign Precision Medicine S.A. has 19,136,126 shares outstanding.

What happened to Oncodesign Precision Medicine S.A.’s price movement after its last earnings report?

Oncodesign Precision Medicine S.A. reported an EPS of -€0.237 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -4.139%.

Which hedge fund is a major shareholder of Oncodesign Precision Medicine S.A.?

Currently, no hedge funds are holding shares in FR:ALOPM

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology